Literature DB >> 25804722

A multilevel approach to network meta-analysis within a frequentist framework.

Teresa Greco1, Valeria Edefonti2, Giuseppe Biondi-Zoccai3, Adriano Decarli4, Mauro Gasparini5, Alberto Zangrillo6, Giovanni Landoni6.   

Abstract

Meta-analysis is a powerful tool to summarize knowledge. Pairwise or network meta-analysis may be carried out with multivariate models that account for the dependence between treatment estimates and quantify the correlation across studies. From a different perspective, meta-analysis may be viewed as a special case of multilevel analysis having a hierarchical data structure. Hence, we introduce an alternative frequentist approach, called multilevel network meta-analysis, which also allows to account for publication bias and the presence of inconsistency. We propose our approach for a three-level data structure set-up: arms within studies at the first level, studies within study designs at the second level and design configuration at the third level. This strategy differs from the traditional frequentist modeling because it works directly on an arm-based data structure. An advantage of using multilevel analysis is its flexibility, since it naturally allows to add further levels to the model and to accommodate for multiple outcome variables. Moreover, multilevel modeling may be carried out with widely available statistical programs. Finally, we compare the results from our approach with those from a Bayesian network meta-analysis on a binary endpoint which examines the effect on mortality of some anesthetics at the longest follow-up available. In addition, we compare results from the Bayesian and multilevel network meta-analysis approaches on a publicly available "Thrombolytic drugs" database. We also provide the reader with a blueprint of SAS codes for fitting the proposed models, although our approach does not rely on any specific software.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical trials; Hierarchical models; Meta-analysis; Multivariate data; Network meta-analysis; Statistical modeling

Mesh:

Substances:

Year:  2015        PMID: 25804722     DOI: 10.1016/j.cct.2015.03.005

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  12 in total

Review 1.  Effectiveness and tolerability of targeted drugs for the treatment of metastatic castration-resistant prostate cancer: a network meta-analysis of randomized controlled trials.

Authors:  Yongquan Wang; Heng Zhang; Wenhao Shen; Peng He; Zhansong Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2018-05-24       Impact factor: 4.553

2.  Comparing efficacy and survivals of initial treatments for elderly patients with newly diagnosed multiple myeloma: a network meta-analysis of randomized controlled trials.

Authors:  Xiaoping Liu; Jiarui Chen; Yuncen A He; Xiangyu Meng; Kaili Li; Colin K He; Shangqin Liu
Journal:  Onco Targets Ther       Date:  2016-12-22       Impact factor: 4.147

3.  Using structural equation modeling for network meta-analysis.

Authors:  Yu-Kang Tu; Yun-Chun Wu
Journal:  BMC Med Res Methodol       Date:  2017-07-14       Impact factor: 4.615

4.  Network meta-analysis: a technique to gather evidence from direct and indirect comparisons.

Authors:  Fernanda S Tonin; Inajara Rotta; Antonio M Mendes; Roberto Pontarolo
Journal:  Pharm Pract (Granada)       Date:  2017-03-15

5.  Effectiveness of multiple therapeutic strategies in neovascular glaucoma patients: A PRISMA-compliant network meta-analysis.

Authors:  Zixian Dong; Jianyang Gong; Rongfeng Liao; Shaojun Xu
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

Review 6.  Mapping the characteristics of network meta-analyses on drug therapy: A systematic review.

Authors:  Fernanda S Tonin; Laiza M Steimbach; Antonio M Mendes; Helena H Borba; Roberto Pontarolo; Fernando Fernandez-Llimos
Journal:  PLoS One       Date:  2018-04-30       Impact factor: 3.240

7.  Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.

Authors:  Qiyan Zheng; Huisheng Yang; Weijing Liu; Weiwei Sun; Qing Zhao; Xiaoxiao Zhang; Huanan Jin; Luying Sun
Journal:  BMJ Open       Date:  2019-09-11       Impact factor: 2.692

8.  Efficacy and Safety of Chemotherapy Regimens in Advanced or Metastatic Bladder and Urothelial Carcinomas: An Updated Network Meta-Analysis.

Authors:  Hong-Chen Qu; Yan Huang; Zhong-Yi Mu; Hang Lv; Qing-Peng Xie; Kai Wang; Bin Hu
Journal:  Front Pharmacol       Date:  2020-01-15       Impact factor: 5.810

9.  Second-line treatment strategy for urothelial cancer patients who progress or are unfit for cisplatin therapy: a network meta-analysis.

Authors:  Huitao Wang; Jianhe Liu; Kewei Fang; Changxing Ke; Yongming Jiang; Guang Wang; Tongxin Yang; Tao Chen; Xin Shi
Journal:  BMC Urol       Date:  2019-12-02       Impact factor: 2.264

10.  Effectiveness of remineralising agents in prevention and treatment of orthodontically induced white spot lesions: a protocol for a systematic review incorporating network meta-analysis.

Authors:  Huimin Hu; Chong Feng; Zhaowei Jiang; Lufei Wang; Sonu Shrestha; Xiaoming Su; Yu Shu; Long Ge; Wenli Lai; Fang Hua; Hu Long
Journal:  Syst Rev       Date:  2019-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.